Henrik Oerum

Title: Discovering the Innovations of Henrik Oerum

Introduction

Henrik Oerum is a prominent inventor based in Copenhagen, Denmark. With a passion for biomedical innovations, he has contributed significantly to the field of pharmaceuticals, particularly through his work at Civi Biopharma, Inc. His innovative spirit has led to cutting-edge research and the development of novel drug delivery systems.

Latest Patents

Henrik Oerum holds a patent for the oral delivery of antisense conjugates targeting PCSK9. This patent presents pharmaceutical compositions designed for effective oral administration. The compositions include an antisense oligonucleotide, specifically CIVI 008, combined with an oral delivery agent such as 5-CNAC. Additionally, the patent describes a capsule formulation that may include a dry blend of CIVI 008 and 5-CNAC, along with a statin, to enhance therapeutic effects in managing cholesterol levels.

Career Highlights

Throughout his career, Oerum has been instrumental in pioneering advancements in drug formulation and delivery. His work at Civi Biopharma, Inc. showcases his dedication to developing innovative therapies that address significant health challenges. His research is characterized by an emphasis on practical applications that can lead to tangible benefits for patients.

Collaborations

Henrik collaborates with skilled professionals in the industry, including Stewart Alwyn Noble and Charles Lester Shear. Together, they strive to push the boundaries of biopharmaceutical research, combining their expertise to develop comprehensive solutions that respond to critical healthcare needs.

Conclusion

Henrik Oerum exemplifies the role of an innovative inventor in the pharmaceutical industry. With his patent speaking volumes about his contributions to the field, his work continues to influence the landscape of drug delivery systems. As he collaborates with talented colleagues, the future holds exciting possibilities for further advancements that could revolutionize patient care.